These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 28551654

  • 1. Overexpression of EGFR as an Independent Prognostic Factor in Adenocarcinoma of the Esophagogastric Junction.
    Aratani K, Komatsu S, Ichikawa D, Ohashi T, Miyamae M, Okajima W, Imamura T, Kiuchi J, Nishibeppu K, Kosuga T, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Tsuda H, Otsuji E.
    Anticancer Res; 2017 Jun; 37(6):3129-3135. PubMed ID: 28551654
    [Abstract] [Full Text] [Related]

  • 2. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.
    Zhang HD, Tang P, Duan XF, Chen CG, Ma Z, Gao YY, Zhang H, Yu ZT.
    J Surg Oncol; 2013 Dec; 108(8):542-9. PubMed ID: 24018956
    [Abstract] [Full Text] [Related]

  • 3. Lymphangiogenesis and prognostic significance of vascular endothelial growth factor C in gastro-oesophageal junction adenocarcinoma.
    Xie LX, Zhai TT, Yang LP, Yang E, Zhang XH, Chen JY, Zhang H.
    Int J Exp Pathol; 2013 Feb; 94(1):39-46. PubMed ID: 23317352
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kato Y, Daiko H, Nishimura M, Katsumata K, Sugiyama Y, Kinoshita T.
    Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of HER-2 Protein is a High-Risk Factor for Patients with Surgically-Resected Stage T3 Gastric Adenocarcinoma.
    Zhang Z, Wang B, Huang G, Wang R, Song J, Lin S, Wang W, Jiang Y, Huang Q, Wang L.
    Clin Lab; 2017 Jan 01; 63(1):115-125. PubMed ID: 28164509
    [Abstract] [Full Text] [Related]

  • 6. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y, Inokuchi M, Takagi Y, Otsuki S, Fujimori Y, Yanaka Y, Kobayashi K, Higuchi K, Kojima K, Kawano T.
    J Clin Pathol; 2015 Oct 01; 68(10):795-801. PubMed ID: 26043748
    [Abstract] [Full Text] [Related]

  • 7. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
    Zhu Z, Wang Y, Li F, Gao J, Han B, Wang R, Xue Y.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb 25; 22(2):149-155. PubMed ID: 30799537
    [Abstract] [Full Text] [Related]

  • 8. Comparison of Prognostic Abilities Among Preoperative Laboratory Data Indices in Patients with Resectable Gastric and Esophagogastric Junction Adenocarcinoma.
    Urabe M, Yamashita H, Watanabe T, Seto Y.
    World J Surg; 2018 Jan 25; 42(1):185-194. PubMed ID: 28741195
    [Abstract] [Full Text] [Related]

  • 9. Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer.
    Jin EH, Lee DH, Jung SA, Shim KN, Seo JY, Kim N, Shin CM, Yoon H, Jung HC.
    World J Gastroenterol; 2015 Jan 14; 21(2):571-7. PubMed ID: 25593477
    [Abstract] [Full Text] [Related]

  • 10. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL, Wu TT, Choi IS, Wang H, Resetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CT.
    Cancer; 2007 Feb 15; 109(4):658-67. PubMed ID: 17211865
    [Abstract] [Full Text] [Related]

  • 11. The role of biological markers of epithelial to mesenchymal transition in oesophageal adenocarcinoma, an immunohistochemical study.
    Prins MJ, Ruurda JP, Lolkema MP, Sitarz R, Ten Kate FJ, van Hillegersberg R.
    J Clin Pathol; 2015 Jul 15; 68(7):529-35. PubMed ID: 25855799
    [Abstract] [Full Text] [Related]

  • 12. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
    Zhang X, Watson DI, Jamieson GG.
    Chin Med J (Engl); 2007 Dec 20; 120(24):2268-70. PubMed ID: 18167216
    [Abstract] [Full Text] [Related]

  • 13. Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophagogastric junction.
    von Rahden BH, Stein HJ, Feith M, Becker K, Siewert JR.
    J Clin Oncol; 2005 Feb 01; 23(4):874-9. PubMed ID: 15681533
    [Abstract] [Full Text] [Related]

  • 14. Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival.
    Singhi AD, Foxwell TJ, Nason K, Cressman KL, McGrath KM, Sun W, Bahary N, Zeh HJ, Levy RM, Luketich JD, Davison JM.
    Am J Surg Pathol; 2015 Apr 01; 39(4):487-95. PubMed ID: 25634752
    [Abstract] [Full Text] [Related]

  • 15. Prognostic Value of the Systemic Inflammation Response Index in Patients with Adenocarcinoma of the Oesophagogastric Junction: A Propensity Score-Matched Analysis.
    Chen Y, Jin M, Shao Y, Xu G.
    Dis Markers; 2019 Apr 01; 2019():4659048. PubMed ID: 31781301
    [Abstract] [Full Text] [Related]

  • 16. Nuclear overexpression of the overexpressed in lung cancer 1 predicts worse prognosis in gastric adenocarcinoma.
    Wang J, Shen H, Fu G, Zhao D, Wang W.
    Oncotarget; 2017 Feb 07; 8(6):9442-9450. PubMed ID: 28038462
    [Abstract] [Full Text] [Related]

  • 17. Factors predicting survival in patients with proximal gastric carcinoma involving the esophagus.
    Zhang YF, Shi J, Yu HP, Feng AN, Fan XS, Lauwers GY, Mashimo H, Gold JS, Chen G, Huang Q.
    World J Gastroenterol; 2012 Jul 21; 18(27):3602-9. PubMed ID: 22826627
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of the location of metastatic lymph nodes in patients with adenocarcinoma of the oesophagogastric junction.
    Liu JF, Jiang T, Shi ZH, Liu XB.
    ANZ J Surg; 2018 Mar 21; 88(3):218-222. PubMed ID: 27444989
    [Abstract] [Full Text] [Related]

  • 19. Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction.
    Sun L, Chen F, Shi W, Qi L, Zhao Z, Zhang J.
    Diagn Pathol; 2014 Jul 16; 9():125. PubMed ID: 25029906
    [Abstract] [Full Text] [Related]

  • 20. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.
    Ielpo B, Pernaute AS, Elia S, Buonomo OC, Valladares LD, Aguirre EP, Petrella G, Garcia AT.
    Interact Cardiovasc Thorac Surg; 2010 May 16; 10(5):704-8. PubMed ID: 20154347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.